| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
177,680,000 |
| Market
Cap: |
7.49(B) |
| Last
Volume: |
1,687,425 |
Avg
Vol: |
1,949,589 |
| 52
Week Range: |
$43.45 - $99.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 568 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,762 |
108,398 |
160,765 |
290,334 |
| Total Sell Value |
$463,948 |
$6,570,910 |
$10,760,022 |
$18,676,003 |
| Total People Sold |
8 |
10 |
10 |
11 |
| Total Sell Transactions |
11 |
52 |
58 |
100 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lidgard Graham Peter |
Chief Science Officer |
• – – |
2016-01-04 |
4 |
AS |
$8.72 |
$30,197 |
D/D |
(3,463) |
209,678 |
|
- |
|
| Arora Maneesh |
COO |
• • – |
2016-01-04 |
4 |
AS |
$8.72 |
$30,075 |
D/D |
(3,449) |
185,365 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2016-01-04 |
4 |
AS |
$8.72 |
$93,740 |
D/D |
(10,750) |
346,869 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2015-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,566 |
213,141 |
|
- |
|
| Arora Maneesh |
COO |
• • – |
2015-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,566 |
188,814 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2015-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,466 |
357,619 |
|
- |
|
| Arora Maneesh |
COO |
• • – |
2015-12-30 |
4 |
OE |
$0.83 |
$41,500 |
D/D |
50,000 |
182,248 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2015-12-23 |
4 |
OE |
$0.83 |
$67,230 |
D/D |
81,000 |
338,335 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2015-11-01 |
4 |
A |
$7.72 |
$9,581 |
D/D |
1,241 |
206,575 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2015-09-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
787 |
337,153 |
|
- |
|
| Megan William J. |
SVP, Finance |
• – – |
2015-08-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
46,807 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2015-07-27 |
4 |
AS |
$24.04 |
$302,399 |
D/D |
(12,579) |
205,334 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2015-07-27 |
4 |
AS |
$24.04 |
$273,719 |
D/D |
(11,386) |
257,335 |
|
- |
|
| Arora Maneesh |
COO |
• • – |
2015-07-27 |
4 |
AS |
$24.04 |
$224,341 |
D/D |
(9,332) |
132,248 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2015-07-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
217,913 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2015-07-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
268,721 |
|
- |
|
| Arora Maneesh |
COO |
• • – |
2015-07-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
141,580 |
|
- |
|
| Carey Thomas D. |
Director |
– • – |
2015-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
13,966 |
36,768 |
|
- |
|
| Sterling Lionel |
Director |
– • – |
2015-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,847 |
102,391 |
|
- |
|
| Thompson David |
Director |
– • – |
2015-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
11,178 |
95,213 |
|
- |
|
| Wyzga Michael S |
Director |
– • – |
2015-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,038 |
6,038 |
|
- |
|
| Napier Katherine S |
Director |
– • – |
2015-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
11,078 |
87,225 |
|
- |
|
| Levangie Daniel J |
Director |
– • – |
2015-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,379 |
51,322 |
|
- |
|
| Doyle James Edward |
Director |
– • – |
2015-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,984 |
16,459 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2015-06-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
340 |
337,940 |
|
- |
|
777 Records found
|
|
Page 28 of 32 |
|
|
0.75 (1.75%) 
